Pleural and Mediastinal Disorders
- Vaccines Do Not Reduce the Risk of Severe COVID-19 Among Certain Cancer Patients
- COVID-19 Vaccine Protection Lasts at Least 6 Months After Second Dose
- Rituximab for Pemphigus Linked to Higher Risk for COVID-19, CMV, Parasitic Infections
- Uptake Low for COVID-19 Vaccine Boosters in Immunocompromised Adults
- Free Spike Antigen Identified in Post-SARS-CoV-2 mRNA Vaccine Myocarditis
- Efzofitimod Safe and Well Tolerated in Patients With Pulmonary Sarcoidosis
- Viral Rebound Uncommon After Molnupiravir, Nirmatrelvir-Ritonavir Therapy
- Respiratory Muscle Training Post-COVID Helps Respiratory Muscle Function, HRQoL
- Pfizer Plans to Charge More Than $100 Per COVID-19 Shot in 2023
- Should Contralateral Bullae/Blebs Be Resected During Bullectomy for PSP?
- Pediatric Primary Spontaneous Pneumothorax Update
- Ambulatory Care With Digital Chest Drainage Safe, Effective for PAL
Conference Coverage
MORE MEETINGS
Clinical Tools
Powered by
Powered by 
